Search results
Two Hot Stocks: AbbVie and IBM
Baystreet· 22 hours agoAbbVie (ABBV) is back to its over $180 highs not seen since March 2024. The firm posted strong second-quarter results, which raised its guidance. AbbVie...
AbbVie: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Finance Canada· 6 days agoNine analysts surveyed by Zacks expected $14.05 billion. AbbVie expects full-year earnings in the range of $10.71 to $10.91 per share. AbbVie shares have ...
S&P 500 Fell By 2.3% But Don't Panic
Baystreet· 6 days agoYesterday’s selling pressure on above-average volume is a potential turning point for stock markets. Nasdaq’s (QQQ) 3.64% decline, due mostly to Nvidia (NVDA) and other technology ...
Bristol Myers surges 10%, its biggest increase since 2008, after boosting profit forecast
Business Insider via Yahoo Finance Canada· 4 days agoAstraZeneca, Roche, Sanofi and AbbVie all raised their profit forecasts for the year during earnings...
Morning Bid: Growth angst or air pocket? Stocks nurse losses
Reuters via Yahoo Finance Canada· 6 days agoThe worst day for the S&P500 since 2022 and mounting central bank easing bets suggest markets'...
Eaton Vance Worldwide Health Sciences Fund's Strategic Moves in Q2 2024: Spotlight on ...
GuruFocus.com via Yahoo Finance Canada· 6 days agoThe stock's average trading price was $138.29 during the quarter. Portfolio Overview As of the...
Factbox-The trades that could bring down short-seller Andrew Left
Reuters via Yahoo Finance Canada· 5 days agoLeft declined to comment when contacted by Reuters. Here are the 23 companies that Left bet on,...
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
BioPharma-Reporter· 5 days agoConsequently commercial demands of many of these next generation therapeutics are lower, ranging...
